Navigation Links
Charles D. McCrary Joins Southern Research Institute Board of Directors
Date:6/5/2008

BIRMINGHAM, Ala., June 5 /PRNewswire-USNewswire/ -- Officials at Southern Research Institute, a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery, drug and vaccine development, advanced engineering, environmental and energy production, today announced that Charles D. McCrary, President and Chief Executive Officer of Alabama Power Company, has joined the company's Board of Directors.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080605/DC24451 )

"Charles McCrary is not only an outstanding leader of one of the South's preeminent corporations, but a driving force in our community," said Carol Z. Garrison, Ph.D., UAB President and Southern Research Board chair. "He understands and appreciates the importance of research, development and technology transfer to quality of life and economic development, and he champions that vision. He will be a strong addition to this board."

McCrary brings more than 30 years of industry experience to the board, having worked in a variety of roles within the Southern Company family since 1970. Most notably, McCrary has served as President of Southern Company Generation, as well as President of Southern Power Company. He currently serves as President and Chief Executive Officer of the Alabama Power Company.

"Joining the board of the Southern Research Institute is particularly gratifying to me, because one of the founders of Alabama Power, Tom Martin, was a driving force behind its creation," said McCrary. "Although many things have changed since the Institute was chartered in 1941, its mission has remained the same: to develop science and technology in a way that improves the overall quality of life for everyone."

Born and raised in Alabama, McCrary graduated from Auburn University with a B.S. in mechanical engineering. In addition to his work at Alabama Power, he serves on the board of directors for Regions Financial Corporation, Mercedes-Benz U.S. International, Inc., Protective Life Corporation, Business Council of Alabama, Birmingham Museum of Art, and the State of Alabama Archives and History Foundation.

"We are honored to welcome Charles McCrary to our Board of Directors," said John A. "Jack" Secrist, III, Ph.D., president and CEO of Southern Research Institute. "His experience and leadership in the fields of power and energy will be a valuable asset to the board as we look to further expand our research and development capabilities, specifically when it comes to environmental and energy production."

About Southern Research Institute

Southern Research Institute is a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery, vaccine and drug development, advanced engineering, environmental research and energy production. To date, Southern Research has discovered six FDA-approved cancer drugs and discovered six additional drugs that are currently in late stage preclinical and early clinical trials. No other company or institution has brought six of its own cancer drug discoveries to market. For more information, please visit http://www.southernresearch.org.

MEDIA CONTACTS:

Rhonda Jung

(205)581-2317

Southern Research Institute

Jung@southernresearch.org

Nicki Polatin

(781)684-0770

Schwartz Communications

Southern@schwartz-pr.com


'/>"/>
SOURCE Southern Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Charles A. Peck, M.D., F.A.C.P. Joins LifeMasters as New Medical Director Focused on Client Experience
2. Ocular Pharma Company Charlesson Announces $2.35MM in New Funding
3. Charles S. Cohen, Pacific Design Center Augment Their Support for AIDS Walk Los Angeles
4. Charles Alan Launches Healthcare-focused Furniture Lines with NuBax Seating Technology, Offering Smart Design and Health Benefits
5. Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare
6. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
7. Charles River Laboratories International Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
8. Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications
9. Charles Lafitte Foundation Pledges $1 Million to the American Cancer Societys Hope Lodge
10. Doug Flutie, Jr. Foundation Grants NAA $10,000 for Burbacher/Charleston Study
11. The California Dental Association Foundation Presents Inaugural Humanitarian Award to USC Mobile Dental Clinics Champion Charles M. Goldstein, DDS, MPH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... The Aesthetic Channel has recently ... Talei has come up with a proprietary technique that he calls the AuraLyft ... have dropped. For all ages, patients can expect to look refreshed, rejuvenated, and revitalized. ...
(Date:6/23/2017)... Georgia (PRWEB) , ... June 23, 2017 , ... ... Negative Breast Cancer Conference from Sept. 18 to 20. , The two-day conference ... (TNBC) subtype with the goal of improving patients’ lives and eliminating racial breast ...
(Date:6/23/2017)... Beach, FL (PRWEB) , ... June 23, 2017 , ... ... in Pinecrest, Florida. This is MD Now’s 28th facility overall and marks the urgent ... Dixie Highway, located one mile North of The Falls shopping mall. The new clinic ...
(Date:6/23/2017)... ... 2017 , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves ... Agency’s (FEMA) recent update of flood zones, more people than ever are in ... enacted to reflect the actual risk in flood zone areas during a time ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... Ulster University, ... June, 2017 from 9 am to 3 pm to present to graduate students exciting ... is an original curriculum project led by The Health Improvement Service of the ...
Breaking Medicine News(10 mins):
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
(Date:6/9/2017)... June 9, 2017 AirXpanders, Inc. (ASX: AXP) ... the design, manufacture, sale and distribution of the AeroForm® ... progress of its commercial roll-out in the ... more than one hundred (100) medical institutions and health ... offers a needle-free alternative for women who choose reconstructive ...
(Date:6/8/2017)...  Less than a month ago, amateur hackers executed ... including hospital networks, in over 150 countries. ... largest online extortion attempts ever recorded. With the increasing ... imperative that providers understand where the risks lie, and ... and many other very real cyber threats.  ...
Breaking Medicine Technology: